The Alzheimer’s Association International Conference (AAIC) took place in Chicago, US, from 22 to 26 July. It is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer’s disease. This year, the congress gathered more than 5,900 leaders in dementia research from all over the world.

We are glad that the AMYPAD project was presented through three activities, which were very well received:

• Oral presentation ‘Amyloid Staging Models: Generalizability and Validation’ by Lyduine E. Collij (VUmc)
• Poster presentation ‘Event-Based Modeling of the Temporal Ordering of Regional β-Amyloid Deposition in the brain’ by Isadora Lopes (VUmc)
• Poster presentation ‘Centiloid PET SUVR analysis using the supratentiorial white matter as reference region’ by Robin Wolz (IXICO).

If you have missed the event, do not hesitate to download the two AMYPAD posters presented on our website here.

In addition to the interest received from the attendees stopping by at our posters, we were thrilled to also see AMYPAD mentioned at different talks during the AAIC. Notably, Gil Rabinovici from the University of California, San Francisco, who highlighted the AMYPAD diagnostic and patient management study.

We also used the AAIC as a fantastic opportunity to hold an AMYPAD gathering on 22 July with all the AMYPAD team members attending the conference to catch up, discuss and do plan for further interactions.

Finally, we used the AMYPAD flyer to communicate about the project as it was distributed at the booth of our partner GE Healthcare. If you are interested by our flyer, download it here.

Next year’s AAIC19 will take place in Los Angeles (US) on 14-18 July. Save the date and mark your calendars for another great conference to network and discuss the latest dementia study results.